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METHODS

Raw material
CP of Vaccinium macrocarpon was obtained from Cranberry Acres, Berwick, NS. The pomace comprised of the remaining wet hulls after the juice was squeezed out. The pomace, obtained as three independent batches of approximately 30 kg each was considered as three replicates and was kept at -20 o C until use.
Chemicals and reagents
The liquid chromatography standards used for the study were obtained as follows: quercetin-3-O-rhamnoside and quercetin-3-O-galactoside were from Indofine Chemical Co. (Hillsborough, N.J., U.S.A.); quercetin-3-O-glucoside, phloridzin, caffeic acid, ferulic acid, protocatechuic acid, myrecetin and chlorogenic acid were from Sigma-Aldrich; quercetin-3-O-rutinoside, (-)-epicatechin, (+)-catechin, and procyanidin B1 and B2 were from ChromaDex (Santa Ana, CA, U.S.A.); and cyanidin-3-O-galactoside was obtained from Extra-Synthase (Paris, France). Ethanol anhydrous was obtained from Commercial Alcohols (Montreal, QC, Canada). Human hepatocellular carcinoma (HepG2) cell line was purchased from American Type Culture Collection (Cederlane, Burlington, ON, Canada). Unless and otherwise stated, all other chemicals, reagents and enzymes used in this study were procured from Sigma Aldrich (Oakville, ON, Canada).
Cell culture
Human hepatocellular carcinoma cells HepG2 (ATCC ® HB-8065™), classified as biosafety level I, were obtained from Cedarlane Labs (Burlington, ON, Canada). The cells were maintained in Eagle's Minimum Essential Medium (EMEM) complete growth medium, supplemented with 10% fetal bovine serum, 100 units/mL penicillin and 100 µg/mL streptomycin in a humidified incubator (5% CO 2 ) at 37°C (VWR International, Mississauga, ON, Canada).
Extraction and isolation of polyphenol fractions
CP (500 g FW) was homogenized with equal volume of deionized water (DI) using a blender (Bead Beater; BioSpec Products, Inc. Bartlesville, OK, USA). The fat components were removed from the slurry by 1 L hexane extraction overnight, followed by liquid-liquid separation. The hexane fraction was discarded and the aqueous mixture was further used for phenolic extraction. The phenolic extraction was carried out using 2 L of acetone/water/acetic acid mix (70/29/1) overnight with continuous stirring at room temperature. The mixture was vacuum filtered and the residue was extracted again using the above explained procedure. After vacuum filtration, both the supernatants were mixed and subjected to rotary vacuum evaporation (Rotavapor, R-200, Buchi, Flawil, Switzerland) at 37 o C until completely dried. The dried extract was dissolved in 200 mL of 50% ethanol in DI water and loaded on to Sepabead column, which was maintained at 25% ethanol and loaded on a 400 g adsorbent resin (Sorbent SP-207-05 Sepabead resin brominated, 250 μm, Sorbent Tech., Norcross, GA, USA) packed into a chromatography column (46 × 2.3 cm, length and internal diameter). The column was equilibrated with deionized water and maintained in 25% ethanol in water. The column was washed with four bed volumes of water (1 L each) to remove all water-soluble compounds, including sugars, until the Brix value of washed eluent reached < 0.01. The water wash eluent was collected for further analysis. The phenolic compounds were eluted with 25, 50, 60, 70, 80 and 100% ethanol (1 L each) to yield six fractions E1-E6 respectively. This was followed by the addition of 25, 50, 60, 70, 80, 90 and 100% acetone to give additional seven fractions A1-A7 respectively. The column was protected from light during the entire process. All the fractions were stored at -20 o C until dried completely using rotary vacuum evaporator.
Spectrophotometric measurements Total phenolic content
The Folin-Ciocalteu assay was used to measure the total phenolic content as described by Singleton and Rossi (10) and modified by Rupasinghe et al. [11] . Calibration curves were plotted using standards at concentrations of 10-750 µmol/L and the results were expressed as gallic acid equivalents (GAE)/g dried weight (DW) of each fraction.
Total anthocyanins
Total anthocyanins were determined using the pH differential method described by Lee et al. [12] . The absorbance was measured at 510 and 700 nm using two buffer systems: potassium chloride buffer pH 1.0 (0.025 M) and sodium acetate buffer pH 4.5 (0.4 M). Total anthocyanins were calculated as equivalents of malvidin-3-glucoside (M3G) according to the equation [1] .
where A= ( A550 -A700, at pH1) -(A550 -A 700, at pH 4.5); MW= molecular weight of M3G = 493.2 g/ mole; DF is dilution factor ;  = Molar extinction coefficient 28,000 ;1 is path length (1 cm) and 1000 is factor for conversion from g to mg.
Total proanthocyanidin content
For total proanthocyanidins content, dimethylcinnamaldehyde (DMAC) method was used as described by Prior et al. [13] and modified by Bhullar and Rupasinghe [14] . Calibration curves of standard were plotted using catechin at 10-500 mg/L.
Total flavonoid content
The total flavonoid content was determined using aluminum chloride colorimetric method [15] . The results were expressed as µmole quercetin equivalents (QE)/100 g FW using standard calibration curve at concentrations of 10-500 µmol/L.
UPLC-ESI-MS analysis
Out of each dried fraction, 10 mg was weighed out and dissolved in 10 mL methanol-acetone [7:3] . The extract was further diluted 10 times prior to filtration through 0. (25-50 V) was optimized for each compound. Individual compounds were identified using the multiple reactions monitoring mode (MRM), using specific precursor-production transitions as reported previously [14] .
Total antioxidant capacity a) The ferric reducing antioxidant power (FRAP) assay
The FRAP assay was used to determine the electron donating potential of the CP samples based on the assay described by Benzie and Strain [16] and modified by Rupasinghe et al. [15] and the results were expressed as µmol Trolox equivalents (TE)/100 g DM using a standard curve of Trolox with a concentration range of 10-500 µmol/L.
b) 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay
The free radical scavenging activity of CP polyphenols was measured using DPPH method described by Lu and Foo (17) and modified by Rupasinghe et al. (15) The IC 50 value, defined as the amount of the sample to scavenge 50% of the DPPH radicals, was calculated from the results.
HepG2 cell viability assay
All the fractions were dried using a rotary vacuum evaporator until a completely dried powder was obtained. All acetone fractions were pooled together and were given label 'A'. From each extract, 10 mg of the sample was dissolved using dimethyl sulfoxide (DMSO), and five different dilutions were prepared in eagle's minimal essential media (EMEM) for cell study. The extracts from all fractions were used to measure their ability to inhibit human liver cancer cell proliferation using HepG2 cell lines [18] . The cell cultures were exposed to various concentrations of the extracts during a 24-h growth period. The anti-proliferative activity of the CP extracts was measured by the ability of viable cells to reduce 3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfenyl)-2Htetrazolium (MTS) to formazan. This product absorbs light at 490 nm and the absorbance was measured using a BMG Fluostar microplate reader (Mandel, QC, Canada). Six replications for each treatment were used to determine the inhibitory effect on cell proliferation. The effective median dose (EC 50 ) was calculated and expressed as mg/mL.
Anti-tyrosinase activity
The anti-tyrosinase effect of each fraction was determined based on the inhibition of the conversion of specific substrate of tyrosinase, L-DOPA into colored product dopachrome, which has maximum absorption at 492 nm. The procedure used was described by Sirat et al. [19] and modified by Ziaullah et al. [20] . The concentration of the fractions demonstrating 50% activity were calculated as an inhibitory concentration (IC 50 ) and compared with a control in terms of mean±standard deviation (SD).
Statistical analysis
A completely randomized design (CRD) was used and all experiments were done in triplicates (n = 3). All measurements were conducted in triplicates and the means were reported. Analysis of variance (ANOVA) was used to test the significance of each variable (p<0.05) and the multiple mean comparison was performed in General Linear Model (SAS V8, Cary, NC, USA) of SAS using Tukey's test method. The differences at the 5% level (p <0.05) were considered statistically significant.
RESULTS AND DISCUSSION Spectrophotometric analyses of polyphenols
The total phenolic content of the crude CP extract as measured by Folin Ciocalteu method was 451 µmole GAE/g DW ( Figure 1 ). Further fractionation was carried out and divided as following based on analytical assays: E1 and E2 rich in phenolic acids and flavan-3-ol monomers, E3-E5 rich in flavonols and anthocyanins, and A1-A7 rich in oligomeric and polymeric proanthocyanidins. Depending on the solvent to water ratio used for the extraction process, the phenolic content varied from 37 to 290 µmole GAE/g of extract. The total phenolic content for ethanol and acetone fractions was found to lie within ranges from 57-290 µmole GAE/g DW and 36-200 µmole GAE/g DW respectively. Flavonols and anthocyanin-rich fractions, E4-E5 contained polyphenol content of 272-290 µmole GAE/g DW, which was significantly higher than all other fractions. Fractions E4 and E5 added together contained 560 µmole GAE/g DW, thereby representing about 24% higher amount than the crude extract.
Total anthocyanins as measured by pH differential method were significantly higher in fractions E3-E5 than all the other fractions, representing more than 50% of the total anthocyanins obtained from all fractions. As expected, E1 and E6 contained the least amount of anthocyanins. However, owing to acid hydrolysis employed in the pH differential method, acetone based fractions (rich in proanthocyanidins) showed varying anthocyanin content.
For total proanthocyanidins, the acetone based fractions contained higher amounts than the ethanol fractions (Figure 1 ). The catechin equivalents found in ethanol fractions, were presumably due to monomeric flavan-3-ol and/or dimeric proanthocyanidin elution in solvents such as ethanol. The crude extract had the highest amount of procyanidin content, because of the presence of monomeric, dimeric, and oligomeric proanthocyanidins. A previous study has reported the presence of both A-and B-type linkages in cranberry procyanidins [5] .
The total flavonoid content of the fractions varied from 415-1128 µmole QE/g DW ( Figure  1 ). The crude extract contained flavonoid content of 1000 µmole QE/g dried fraction, which was significantly higher than most of the ethanol and acetone based fractions. Similar to anthocyanin data, fractions E3 and E5 were observed as the highest total flavonoid containing fractions, followed by fractions E1, E2, and E4.
UPLC-MS characterization of polyphenols
The LCMS analysis of polyphenols resulted in varying amounts than spectrophotometric measurements (Figure 2 ). This could be partly due to dissimilar absorbance of different phenolic compounds in the spectrophotometric procedures, but it also indicates the presence of unidentified phenolic compounds in the extracts, for example, benzoic acids and tannins. Most of the dihydrochalcones (phloridzin, phloretin), phenolic acids (protocatechuic acid, chlorogenic acid, caffeic acid, ferulic acid, isoferulic acid), flavonols (myrecetin, quercetin and its glactosides, glucosides, rhamnosides and rutinosides), anthocyanins (glucosides, galactosides and rutinosides of cyanidin, malvidin, delphinidin and peonidins), monomeric flavan-3-ols (catechin, epicatechin, epigallocatechin, epigallocatechin gallate) were concentrated in fractions from E1-E6. Similar to the results described above, the crude fraction contained the highest amount of most of these compounds, except for total anthocyanins. However, the total phenolic compounds (sum of total phenolic acids, flavonols, catechins, flavan-3-ols and anthocyanins from UPLC-ESI-MS analysis) were the highest in fractions E4 and E5, representing values of 274 and 227 mg/g DW respectively. Fractions E4 and E5 combined together represented about 43%, 27% and 55% of the total dihydrochalcones, phenolic acids, and total flavonols respectively.
Figure 2. UPLC-ESI-MS analysis of each fraction obtained from cranberry pomace.
Bars represent standard errors (n = 3). Bars with different letters indicate that values are statistically different (p <0.05). C, crude; E1-E6, ethanol based fractions; A1-A7, acetone based fractions. Dihydrochalcones: phloridzin+phloretin; Phenolic acids: coumaric acid+protocatechuic acid+chlorogenic acid+caffeic acid+ferulic acid+isoferulic acid; total flavonols: myrecetin+quercetin(Q)+Q. galactoside+Q. glucoside+Q. arabinoside+Q. rhamnoside+Q. rutinoside; total flavan-3-ols: catechin+epicatechin+epicatechin gallate+epigallocatechin gallate; Anthocyanins:delphinidin-3-rutinoside+delphinidin-3-galactoside+cyanidin-3-rutinoside+cyanidin-3-galactoside +peonidin-3-galactoside+malvinidin-3-galactoside.
However, the total flavan-3-ol content of fraction E4 and E5 was significantly lower than the other ethanol fractions. Overall, the fractions E4 and E5 represented about 254.4 mg of total phenolics as quantified by UPLC-ESI-MS per g DW. About 83% of the total phenolics in E4 and E5 as measured by UPLC-ESI-MS were represented by flavonols. Similar to a previous report , most of the flavonols found were glycosides of quercetin and myrcetin, although moderate amounts of aglycones were observed as well. Our UPLC-ESI-MS data were consistent with previous reports which showed the presence of the measured different classes of phenolic compounds in by-products of cranberry-juice processing [21, 22] .
Characterization by UPLC-ESI-MS provided an insight about multiple anthocyanin glycosides in CP (Figure 2 ), including the galactosides and glucosides of cyanidin, malvidin, peonidin, delphidins and rutinosides of cyanidin, and delphinidin. Interestingly, rutinosides of delphinidin and cyanidins were the most prominent anthocyanins, followed by glucoside and galactoside of delphinidin. Anthocyanins started eluting after fraction E2; therefore, matched with the pH differential method results, fractions E3-E5 were found rich in most types of anthocyanins. Similar to the previous studies, our report demonstrated the occurrence of galactosides of peonidin and cyanidin; however, no analysis on the arabinosides of peonidin and cyanidins was made as reported in previous studies.
Anti-oxidant capacity
The FRAP data revealed that almost all the fractions are free radical-scavengers and primary antioxidants, which combat the free radicals (Figure 3) . Fraction A1 (rich in proanthocyanidins) contained the highest total FRAP content (2609.4 µmol TE/g DW), which was about 40% higher than E4 and E5 fractions, which were rich in flavonols and dihydrochalcones. Additionally, other hydrophobic fractions, A3 and A4 (containing proanthocyanidins), were also found to have high FRAP values. Conversely, fractions rich in phenolic acids (E1-E3) represented the lowest FRAP values of <500 µmole TE/g DW. These data results are in agreement with a recent study which showed that large polyphenols (i.e. proanthocyanidins and flavonoid glycosides) containing fractions of cranberry showed the highest anti-oxidant activity [7] among all fractions. It is established that a wide range of phenolics in cranberry known to contribute to the characteristic antioxidant activity profile include the catechins, quercetin, p-coumaric acid, chlorogenic acid, myricetin, trans-resveratrol, and cyanidin/peonidin-3-galactoside/arabinoside [23] . Moreover, the capability of a particular phenolic compound towards the total antioxidant capacity of cranberry and its by-products could also depend on both the relative concentration of individual compounds, as well as possible synergistic action of different antioxidant compounds in the fruit [23] .
Similar to FRAP, the IC 50 values for DPPH assay for the fraction E4 and E5 were the lowest amongst all fractions, representing 10 and 11 mg/L respectively (Figure 3) . The IC 50 value for the crude extract was 12.3 mg/L. The correlation coefficient between DPPH radical scavenging activity and reducing power is rather small, indicating some compounds which demonstrated high DPPH scavenging activity may not show reducing power activity due to the fact that ferrous reducing power is a method for measuring total reducing power of electron donating substances, while DPPH assay is a method for measuring the ability of antioxidant molecules to quench DPPH free radical.
Anti-proliferative activity against human hepatocellular carcinoma HepG2 cells
It is a well-known fact that liver is one of the main sites of flavonoid metabolism. Therefore, it is interesting to see the effects of flavonoid and phenolic acid rich fractions against human hepatocellular carcinoma cell line HepG2. Anti-proliferative activity of fractions E2 was the highest (≥85% at a concentration of 100 mg/L), followed by fractions E1, E6, and C, that were nonsignificantly different from each other (Appendix A). Even at lower concentrations of 10 and 25 mg/L, fractions E1 and E2 demonstrated anti-proliferation of 50% and above. In general, a doseresponse relationship was observed between the tested fractions and their associated antiproliferative action. The IC 50 values (mg/L) for the tested fractions were as following: E1 (7.8)<E2 (15.8)<E3 (20.1)<E4=C (62.3)<C (63.6)<E6 (77.8)=A (77.9)<E5 (93.5) as shown in Figure 4 . The results suggested that E1 and E2 being rich in short chain phenolic acids and monomeric flavan-3-ols, were able to penetrate through the cell membrane efficiently, thereby giving higher anti-proliferation activity. The present data support a study by Vu et al. [2] , which demonstrated that water soluble phenolic extracts of cranberry and its products (mainly phenolic acids and their derivatives) effectively inhibited the proliferation of HT-29 and LS-513 colon cancer cells. Furthermore, these phenolic acids such as dicaffeoylquinic acid have been shown to exhibit anti-tumor activity against liver cancer [24] . It can be suggested that the observed antiproliferative activity of given CP extracts could be due to the combined effects of several bioactive compounds present in the fractions, and this symbiotic action can be better than any single compound. Therefore, the results obtained in our study on the anti-proliferative activity of extracts containing polar phenolic acids and flavan-3-ol monomers against HepG2 liver cancer cells are scientifically reasonable. However, further investigations are required to confirm our observations. Crude extract was found to be less effective in terms of its anti-proliferative activity, followed by fractions A, E5, and E6. This was however, different from what was observed in the case of anti-oxidant capacity data, where fractions E4 and E5 came out be the most effective in exhibiting anti-oxidant capacities. The relationship between the quantity of total phenolic contents and the anti-proliferative concentration was not established for all the tested fractions. For instance, it was observed that the total phenolic contents of the CP fractions containing anthocyanins or flavonols (E4-E5) were very high ( Figure 2) ; however, the concentrations required against HepG2 cancer cells were significantly higher than that of other fractions with lower phenolic contents (E-E3). A plausible reason for this could be that the anti-proliferative activity of different fractions might depend on some main bioactive components and their interaction or synergistic effects. Our data were in agreement to results reported by Vu et al [2] , which showed that the fractions containing the highest total phenolic content were not effective in inhibiting the growth of colon cancer cells.
Anti-tyrosinase activity
The tyrosinase activity of CP fractions was determined using the L-tyrosine oxidation assay. The absorbance at 490 nm decreases as a result of the reaction of melanin synthesis was interrupted. The results were expressed in IC 50 value (Figure 4) . All of the fractions showed strong antityrosinase activities and the activity of the given fractions increased with increasing concentrations, i.e. 10-500 mg/L. The IC 50 values of fractions were in the increasing order: E1 (6.1) < E2 (6.2) < E4 (6.5) < E6 (6.9) < E5 (7.3) < A (8.2) < C (8.6) < E3 (9.1) mg/L. Similar to anti-proliferation results, fractions E1 and E2 (rich in phenolic acids and catechins) were found to be the most effective in terms of inhibiting tyrosinase activity. This trend was followed by fraction E4 and E5 (enriched in flavonols). However, crude extract was found to be least effective in inhibiting tyrosinase activity.
In addition to the phenolic compounds determined in our study, cranberry is also known to be rich in arbutin, a potent antioxidant with a hydroquinone moiety that inhibits the activity of tyrosinase and inhibits melanosome maturation [25] . The low IC 50 values of CP fractions are indicative of the presence of highly bioactive compounds against tyrosinase inhibition. The modulation of human skin pigmentation has been in demand for cosmetic and pharmaceutical applications for many years. Hydroquinones, kojic acid, and their derivatives are some of the whitening agents commonly used. However, these products have also been associated with many side effects. Our study is the first to present the anti-tyrosinase activity of CP based fractions in vitro. The CP being rich in tannins may employ the characteristic feature that tannins ability to bind with proteins as a mechanism of tyrosinase inhibitors. These interesting results would provide information regarding the feasibility of developing a natural CP-based extract as a source of cosmetic ingredient with a skin-whitening and/or anti-aging property.
CONCLUSIONS
The results from this study showed that CP fractions contain a wide variety of bioactive compounds, including flavonols, flavan-3-ols, phenolic acids, anthocyanins, and proanthocyanidins. Fractions E4 and E5 (rich in flavonols and anthocyanins), followed by A1 (rich in proanthocyanidins) exhibited strong anti-oxidant capacity as determined by FRAP and DPPH assays. The CP fractions demonstrated a dose-dependent inhibition of human hepatocellular carcinoma HepG2 cells, with E1 (rich in phenolic acids and flavan-3-ols with IC 50 = 7.8 mg/L) presenting the highest inhibitory activity. Additionally, a similar concentration of E1 and E2 (IC 50 = 6.1-6.2 mg/L), followed by E4 (IC 50 = 6.9) demonstrated the potent antityrosinase inhibitory activity. Overall, all fractions of CP exerted biological activity greater than that demonstrated by the crude extract. To our knowledge, this is the first study to demonstrate the potential of CP fractions against human liver cancer cells and anti-tyrosinase activity in vitro. Nonetheless, further studies are required to confirm the mechanisms (apoptosis or necrotic) in which these fractions arrest the growth of human liver cancer cell lines. The anti-proliferative activity of CP fractions may be used with other anticancer agents as adjuvants to have synergistic or additive actions in treatment of liver cancer. These results suggest that CP, instead of being land disposed, could be exploited as a potential source of natural antioxidant and other health promoting biologically active agents.
Abbreviation: CP, cranberry pomace; DMAC, dimethylcinnamaldehyde; DMSO, dimethyl sulfoxide; DPPH, 2,2-Diphenyl-1-picrylhydrazyl; EMEM, Eagle's Minimum Essential Medium; ESI, electrospray ionization; FRAP, ferric reducing antioxidant power; GAE, gallic acid equivalents; HepG2, human hepatocellular carcinoma; ME, malvidin-3-glucoside equivalents; MTS, 3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfenyl)-2H tetrazolium; QE, quercetin equivalents; TE, Trolox equivalents; UPLC-MS, ultra-high performance liquid chromatography mass spectrometry.
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